KL
Kamlesh Lalchand Prithiani
About Kamlesh Lalchand Prithiani
Kamlesh Lalchand Prithiani has 23 years in corporate governance. Holds Director role. Currently with 1 company, including Krishh Pharmaceuticals And Distributors Private Limited and Satnam Medico Pharma Distributors Private Limited. Formerly with 2 companies, such as Cartel Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Satnam Medico Pharma Distributors Private Limited
U52310MH2003PTC139821
|
Director | 01 Apr 2003 | 2003 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Cartel Pharmaceuticals Private Limited
U24239MH2008PTC186620
|
Director | 10 Aug 2017 | 2008 | Strike Off |
Krishh Pharmaceuticals And Distributors Private Limited
U51909MH2020PTC338093
|
Director | 21 Feb 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kamlesh Lalchand Prithiani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kamlesh Lalchand Prithiani
Kamlesh Lalchand Prithiani has 23 years in corporate governance. Holds Director role. Currently with 1 company, including Krishh Pharmaceuticals And Distributors Private Limited and Satnam Medico Pharma Distributors Private Limited. Formerly with 2 companies, such as Cartel Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.
Kamlesh Lalchand Prithiani is associated with 1 company as Director.
Kamlesh Lalchand Prithiani has expertise in General Business.
Kamlesh Lalchand Prithiani has 23 years in corporate governance.